Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”

Detalles Bibliográficos
Autor principal: Rascati, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629126/
https://www.ncbi.nlm.nih.gov/pubmed/28528515
http://dx.doi.org/10.1007/s40268-017-0185-9
_version_ 1783269001677242368
author Rascati, Karen
author_facet Rascati, Karen
author_sort Rascati, Karen
collection PubMed
description
format Online
Article
Text
id pubmed-5629126
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-56291262017-10-17 Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode” Rascati, Karen Drugs R D Letter to the Editor Springer International Publishing 2017-05-20 2017-09 /pmc/articles/PMC5629126/ /pubmed/28528515 http://dx.doi.org/10.1007/s40268-017-0185-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Rascati, Karen
Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
title Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
title_full Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
title_fullStr Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
title_full_unstemmed Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
title_short Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
title_sort comment on: “net budgetary impact of ferric citrate as a first-line phosphate binder for the treatment of hyperphosphatemia: a markov microsimulation mode”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629126/
https://www.ncbi.nlm.nih.gov/pubmed/28528515
http://dx.doi.org/10.1007/s40268-017-0185-9
work_keys_str_mv AT rascatikaren commentonnetbudgetaryimpactofferriccitrateasafirstlinephosphatebinderforthetreatmentofhyperphosphatemiaamarkovmicrosimulationmode

Ejemplares similares